Bezisterim – the Best Long COVID Drug Trial Yet? BioVie Aims for a Big, Phase III Trial
Geoff’s Narration The GIST The Second Generation Makes Progress… Last year, UCSF researcher and LIINC cofounder Dr. Michael Peluso compared first- and second…
Continue reading at healthrising.org.
No webmentions yet
Replies, likes, reposts, and mentions will show up here when they arrive.